Loading company…
Verigen develops biopharmaceutical therapies for healthcare providers and patients.
Verigen develops biopharmaceutical therapies for the global healthcare market, with a presence in Europe. Founded in 1999 and based in Leverkusen, Germany, the company was acquired by Genzyme Corporation in February 2005.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in